2/6/24 16:08 | 2/2/24 | REGN | Regeneron Pharmaceuticals, Inc. | NY | Health | Drug | Pharmaceutical Preparations | Landry Robert E | NY | O | EVP Fina | M.d | 152 | 378.98 | 0 | 0 | 2 | 24 | D | | | | | | | | | | | | | | |
2/2/24 16:02 | 1/31/24 | REGN | Regeneron Pharmaceuticals, Inc. | NY | Health | Drug | Pharmaceutical Preparations | Landry Robert E | NY | O | EVP Fina | M.d | 152 | 378.98 | 0 | 0 | 2 | 24 | D | | | | | | | | | | | | | | |
1/25/24 16:17 | 1/23/24 | REGN | Regeneron Pharmaceuticals, Inc. | NY | Health | Drug | Pharmaceutical Preparations | Landry Robert E | NY | O | EVP Fina | M.dm | 606 | 378.98 | 0 | 2 | 7 | 24 | D | | | | | | | | | | | | | | |
1/18/24 16:02 | 1/17/24 | REGN | Regeneron Pharmaceuticals, Inc. | NY | Health | Drug | Pharmaceutical Preparations | Landry Robert E | NY | O | EVP Fina | M.d | 189 | 378.98 | 0 | 1 | 2 | 23 | D | | | | | | | | | | | | | | |
1/17/24 16:03 | 1/12/24 | REGN | Regeneron Pharmaceuticals, Inc. | NY | Health | Drug | Pharmaceutical Preparations | Landry Robert E | NY | O | EVP Fina | M.d | 303 | 378.98 | 0 | 1 | 4 | 23 | D | | | | | | | | | | | | | | |
1/8/24 16:02 | 1/4/24 | REGN | Regeneron Pharmaceuticals, Inc. | NY | Health | Drug | Pharmaceutical Preparations | Landry Robert E | NY | O | EVP Fina | M.d | 189 | 378.98 | 0 | 1 | 2 | 23 | D | | | | | | | | | | | | | | |
1/4/24 16:19 | 1/2/24 | REGN | Regeneron Pharmaceuticals, Inc. | NY | Health | Drug | Pharmaceutical Preparations | Landry Robert E | NY | O | EVP Fina | M.dm | 663 | 378.98 | 0 | 2 | 8 | 23 | D | | | | | | | | | | | | | | |
12/29/23 16:05 | 12/27/23 | REGN | Regeneron Pharmaceuticals, Inc. | NY | Health | Drug | Pharmaceutical Preparations | Landry Robert E | NY | O | EVP Fina | M.dm | 606 | 378.98 | 0 | 2 | 8 | 22 | D | | | | | | | | | | | | | | |
12/14/23 16:08 | 12/13/23 | REGN | Regeneron Pharmaceuticals, Inc. | NY | Health | Drug | Pharmaceutical Preparations | Landry Robert E | NY | O | EVP Fina | M.d | 379 | 378.98 | 0 | 1 | 5 | 22 | D | | | | | | | | | | | | | | |
8/25/23 16:02 | 8/23/23 | REGN | Regeneron Pharmaceuticals, Inc. | NY | Health | Drug | Pharmaceutical Preparations | Landry Robert E | NY | O | EVP Fina | S | -188 | 844.00 | 0 | 0 | -1 | 32 | D | | | | | | | | | | | | | | |
3/29/23 16:07 | 3/27/23 | REGN | Regeneron Pharmaceuticals, Inc. | NY | Health | Drug | Pharmaceutical Preparations | Landry Robert E | NY | O | EVP Fina | M.d | 1,442 | 379.60 | 0 | 4 | 13 | 32 | D | | | | | | | | | | | | | | |
3/29/23 16:07 | 3/27/23 | REGN | Regeneron Pharmaceuticals, Inc. | NY | Health | Drug | Pharmaceutical Preparations | Landry Robert E | NY | O | EVP Fina | S.dm | -980 | 823.20 | 0 | -1 | -4 | 32 | D | | | | | | | | | | | | | | |
2/7/23 16:09 | 2/3/23 | REGN | Regeneron Pharmaceuticals, Inc. | NY | Health | Drug | Pharmaceutical Preparations | Landry Robert E | NY | O | EVP Fina | S.dm | -1,158 | 776.80 | 0 | -1 | -4 | 32 | D | | | | | | | | | | | | | | |
2/7/23 16:09 | 2/3/23 | REGN | Regeneron Pharmaceuticals, Inc. | NY | Health | Drug | Pharmaceutical Preparations | Landry Robert E | NY | O | EVP Fina | M.d | 1,146 | 381.92 | 0 | 3 | 10 | 32 | D | | | | | | | | | | | | | | |
12/12/22 16:34 | 12/8/22 | REGN | Regeneron Pharmaceuticals, Inc. | NY | Health | Drug | Pharmaceutical Preparations | Landry Robert E | NY | O | EVP Fina | M.d | 1,146 | 381.92 | 0 | 3 | 11 | 29 | D | | | | | | | | | | | | | | |
12/2/22 16:05 | 12/1/22 | REGN | Regeneron Pharmaceuticals, Inc. | NY | Health | Drug | Pharmaceutical Preparations | Landry Robert E | NY | O | EVP Fina | M.d | 955 | 381.92 | 0 | 3 | 9 | 29 | D | | | | | | | | | | | | | | |
12/2/22 16:05 | 12/2/22 | REGN | Regeneron Pharmaceuticals, Inc. | NY | Health | Drug | Pharmaceutical Preparations | Landry Robert E | NY | O | EVP Fina | S.d | -462 | 756.66 | 0 | -1 | -2 | 29 | D | | | | | | | | | | | | | | |
11/2/22 16:04 | 10/31/22 | REGN | Regeneron Pharmaceuticals, Inc. | NY | Health | Drug | Pharmaceutical Preparations | Landry Robert E | NY | O | EVP Fina | M.d | 764 | 381.92 | 0 | 2 | 7 | 29 | D | | | | | | | | | | | | | | |
11/2/22 16:04 | 11/1/22 | REGN | Regeneron Pharmaceuticals, Inc. | NY | Health | Drug | Pharmaceutical Preparations | Landry Robert E | NY | O | EVP Fina | S.d | -365 | 758.06 | 0 | 0 | -2 | 29 | D | | | | | | | | | | | | | | |
10/18/22 16:06 | 10/14/22 | REGN | Regeneron Pharmaceuticals, Inc. | NY | Health | Drug | Pharmaceutical Preparations | Landry Robert E | NY | O | EVP Fina | M.d | 573 | 381.92 | 0 | 2 | 5 | 29 | D | | | | | | | | | | | | | | |
10/18/22 16:06 | 10/17/22 | REGN | Regeneron Pharmaceuticals, Inc. | NY | Health | Drug | Pharmaceutical Preparations | Landry Robert E | NY | O | EVP Fina | S.d | -265 | 739.50 | 0 | 0 | -1 | 29 | D | | | | | | | | | | | | | | |